01 2ELACESTRANT DIHYDROCHLORIDE
02 1TAGRAXOFUSP-ERZS
03 1Tagraxofuspum
01 2STEMLINE THERAP
02 1STEMLINE THERAPEUTICS INC
03 1Stemline Therapeutics Switzerland GmbH
01 1Inf Conc
02 1SOLUTION;INJECTION
03 2TABLET;ORAL
01 11000MCG
02 11mg/ml
03 1EQ 345MG BASE
04 1EQ 86MG BASE
01 1Switzerland
02 3USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ORSERDU
Dosage Strength : EQ 86MG BASE
Packaging :
Approval Date : 2023-01-27
Application Number : 217639
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ORSERDU
Dosage Strength : EQ 345MG BASE
Packaging :
Approval Date : 2023-01-27
Application Number : 217639
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : SOLUTION;INJECTION
Brand Name : ELZONRIS
Dosage Strength : 1000MCG
Packaging :
Approval Date :
Application Number : 761116
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : Switzerland
Dosage Form : Inf Conc
Brand Name : Elzonris
Dosage Strength : 1mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
LOOKING FOR A SUPPLIER?